This project involves three primary lines of research to gain insights into the effects of sex steroid hormones on cognitive function: 1) sex differences in cognitive function; 2) changes in cognition in relation to natural fluctuations in endogenous hormones; and 3) changes in cognition associated with exogenous hormone intervention. Studies of sex differences in cognitive function provide indirect support for hormonal modulation of cognitive function and point to cognitive domains that might be particularly sensitive to the effects of sex steroid hormones. Studies of changes in cognition across the menstrual cycle indicate that fluctuations in estrogen are associated with fluctuations in performance on cognitive tests on which women typically show an advantage. Studies of changes in cognition in association with the use of hormone replacement therapy (HRT) suggested a lower risk of Alzheimer's disease among women receiving HRT. A recent study suggested a selective beneficial effect of HRT on memory, particularly verbal memory, among healthy older women receiving HRT. This pattern of results is notable in light of the female advantage on tests of verbal memory. However, there is little evidence that HRT influences performance on other cognitive tasks on which women show a comparative advantage over men. This suggests that the effects of hormones on cognition may be age-specific. Neuroimaging studies provide insights into the neural underpinnings of hormone effects on cognitive performance. Hormone therapy is associated with changes in patterns of brain activation during performance of verbal and figural tasks and with increased blood flow to the hippocampus over time. These findings increase the biological plausibility that estrogen might help to prevent age-associated declines in cognition. Randomized clinical trials are needed to confirm this relationship and are underway. If estrogen may help to protect against cognitive decline, then medications that block estrogen in some body tissues might increase the risk for cognitive decline. CO-STAR is a recently initiated study of longitudinal change in cognition in 1800 women receiving such medications. These studies may provide critical information for women and their physicians about how commonly used medications might effect cognitive function.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Intramural Research (Z01)
Project #
1Z01AG000192-02
Application #
6668440
Study Section
(LPC)
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Aging
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Maki, Pauline M; Ernst, Monique; London, Edythe D et al. (2007) Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function. J Clin Endocrinol Metab 92:4107-14
Maki, P M; Zonderman, A B; Resnick, S M (2001) Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am J Psychiatry 158:227-33
Maki, P M; Resnick, S M (2001) Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. Neuroimage 14:789-801
Resnick, S M; Maki, P M (2001) Effects of hormone replacement therapy on cognitive and brain aging. Ann N Y Acad Sci 949:203-14